$NGTF
NightFood Holdings, Inc. Stock $ngtf

$ngtf Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000101376223003824 Filed on October 13, 2023

Income Statement

Concept	2023 Q4	2023 Q2	2023
Revenue	$601.00	$29.51K	$133.5K
YoY Change	-95.5%	-75.92%	-69.91%
Cost Of Revenue	$1.000K	$53.69K	$279.3K
YoY Change	-97.62%	-57.53%	-42.55%
Gross Profit	-$400.00	-$24.18K	-$145.8K
YoY Change	-98.6%	523.2%	242.14%
Gross Profit Margin	-66.56%	-81.94%	-109.26%
Selling, General & Admin	$53.44K	$404.8K	$542.8K
YoY Change	-48.76%	44.62%	10.17%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$175.3K	$404.8K	$1.944M
YoY Change	-74.63%	44.62%	-18.09%
Operating Profit	-$174.7K	-$429.0K	-$1.810M
YoY Change	-74.22%	51.16%	-6.18%
Interest Expense	-$115.3K	-$400.1K	-$2.312M
YoY Change	-96.62%	60.78%	323.75%
% of Operating Profit
Other Income/Expense, Net	-$201.5K	-$103.6K	-$3.940M
YoY Change		-279.49%	8054.68%
Pretax Income	-$491.5K	-$974.2K	-$5.750M
YoY Change	-89.22%	105.14%	127.87%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$491.5K	-$990.7K	-$5.750M
YoY Change	-89.22%	108.6%	127.87%
Net Earnings / Revenue	-81772.71%	-3357.1%	-4308.33%
Basic Earnings Per Share	$0.00		-$0.07
Diluted Earnings Per Share	$0.00	-$0.01	-$0.07
COMMON SHARES
Basic Shares Outstanding	126.9M shares	120.6M shares	103.9M shares
Diluted Shares Outstanding	127.2M shares		103.9M shares

Balance Sheet

Concept	2023 Q4	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.800K	$44.19K	$44.19K
YoY Change	-88.17%	-84.27%	-84.27%
Cash & Equivalents	$5.804K	$44.19K
Short-Term Investments
Other Short-Term Assets	$133.4K	$92.73K	$92.73K
YoY Change	29.49%	-32.71%	-32.71%
Inventory	$133.4K	$276.2K	$276.2K
Prepaid Expenses	$11.51K
Receivables	$30.28K	$33.40K	$33.40K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$302.9K	$446.5K	$446.5K
YoY Change	-55.47%	-47.09%	-47.09%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles		$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$302.9K	$446.5K	$446.5K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$302.9K	$446.5K	$446.5K
YoY Change	-55.47%	-47.09%	-47.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$604.8K	$563.7K	$665.6K
YoY Change	17.43%	140.76%	184.27%
Accrued Expenses	$143.0K		$40.78K
YoY Change	429.44%
Deferred Revenue
YoY Change
Short-Term Debt	$2.197M	$1.492M	$1.492M
YoY Change	-33.77%	333.45%	333.45%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.106M	$2.198M	$2.198M
YoY Change	-19.53%	280.1%	280.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.106M	$2.198M	$2.198M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.106M	$2.198M	$2.198M
YoY Change	-19.53%	280.1%	280.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$36.93M	-$34.99M
YoY Change	-1.64%	24.51%
Common Stock	$127.2K	$123.6K
YoY Change	27.46%	34.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.803M	-$1.752M	-$1.752M
YoY Change
Total Liabilities & Shareholders Equity	$302.9K	$446.5K	$446.5K
YoY Change	-55.47%	-47.09%	-47.09%

Cashflow Statement

Concept	2023 Q4	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$491.5K	-$990.7K	-$5.750M
YoY Change	-89.22%	108.6%	127.87%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$250.0K	-$217.5K	-$1.213M
YoY Change	-22.73%	-36.23%	-41.39%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	250.4K	235.1K	$976.5K
YoY Change	64.57%	135.11%	-25.4%
NET CHANGE
Cash From Operating Activities	-250.0K	-217.5K	-$1.213M
Cash From Investing Activities		0.000
Cash From Financing Activities	250.4K	235.1K	$976.5K
Net Change In Cash	380.0	17.52K	-$236.7K
YoY Change	-100.22%	-107.26%	-68.9%
FREE CASH FLOW
Cash From Operating Activities	-$250.0K	-$217.5K	-$1.213M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Registrant Name EntityRegistrantName	NIGHTFOOD HOLDINGS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3885019
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	520 White Plains
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Road-Suite 500
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Tarrytown
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10591
CY2023	dei	Local Phone Number LocalPhoneNumber	888-888-6444
CY2023	dei	City Area Code CityAreaCode	888
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	7902506	usd
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	126921301	shares
CY2023	dei	Auditor Firm AuditorFirmId	6778
CY2023	dei	Auditor Name AuditorName	Gries & Associates, LLC
CY2023	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	44187	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	280877	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33396	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	93674	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	276202	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	331531	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	92726	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	137797	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	446511	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	843879	usd
CY2023Q2	us-gaap	Assets Assets	446511	usd
CY2022Q2	us-gaap	Assets Assets	843879	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	604516	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	234152	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	101876	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1491719	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	344151	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2198111	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	578303	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1751600	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	265576	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	446511	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	843879	usd
CY2023	us-gaap	Revenues Revenues	133456	usd
CY2022	us-gaap	Revenues Revenues	443538	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	279277	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	486163	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	166656	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	596331	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	542803	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	492713	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	954918	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	797666	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1943654	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2372873	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1810198	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1929335	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1265893	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	275423	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	170505	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	48309	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	2141626	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	270210	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-361500	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3939524	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-593942	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5749722	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2523277	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1136946	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	381310	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6886668	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2904587	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103889833	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87521595	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1110001	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	214125	usd
CY2022	ngtf	Issued From Private Placement IssuedFromPrivatePlacement	335000	usd
CY2022	ngtf	Issued Financing Cost IssuedFinancingCost	-26800	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	931272	usd
CY2022	ngtf	Warrants Issued As Financing Cost WarrantsIssuedAsFinancingCost	170210	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	39045	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2523277	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	265576	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	77110	usd
CY2023	ngtf	Units Issued Under Regulation A Offering UnitsIssuedUnderRegulationAOffering	229729	usd
CY2023	ngtf	Common Stock Issued As Financing Cost CommonStockIssuedAsFinancingCost	104515	usd
CY2023	ngtf	Stock Issued During Period Value Warrants Exercise In Cash StockIssuedDuringPeriodValueWarrantsExerciseInCash	276066	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	342000	usd
CY2023	ngtf	Common Stock Issued Under Notice Of Conversion CommonStockIssuedUnderNoticeOfConversion	91500	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	62850	usd
CY2023	ngtf	Stock Issued During Period Value Warrants Issued As Financing Cost Associated With Convertible Notes StockIssuedDuringPeriodValueWarrantsIssuedAsFinancingCostAssociatedWithConvertibleNotes	603689	usd
CY2023	ngtf	Warrants Issued As Financing Cost WarrantsIssuedAsFinancingCost	1823450	usd
CY2023	ngtf	Adjustments To Additional Paid In Capital Warrant Dilutive Adjustment AdjustmentsToAdditionalPaidInCapitalWarrantDilutiveAdjustment	185669	usd
CY2023	ngtf	Adjustments To Additional Paid In Capital Warrant Dilutive Other Adjustment AdjustmentsToAdditionalPaidInCapitalWarrantDilutiveOtherAdjustment	-64032	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5749722	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1751600	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5749722	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2523277	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	77110	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	214125	usd
CY2023	ngtf	Stock Issued For Financing Cost StockIssuedForFinancingCost	104515	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1265893	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	275423	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	62850	usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	39045	usd
CY2023	ngtf	Warrants And Returnable Warrants Issued For Financing1 WarrantsAndReturnableWarrantsIssuedForFinancing1	1823450	usd
CY2022	ngtf	Warrants And Returnable Warrants Issued For Financing1 WarrantsAndReturnableWarrantsIssuedForFinancing1	170210	usd
CY2023	ngtf	Financing Cost Due To Conversion Price Changes FinancingCostDueToConversionPriceChanges	-64033	usd
CY2023	ngtf	Consulting Fee Due To Conversion Price Changes ConsultingFeeDueToConversionPriceChanges	185669	usd
CY2023	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-361500	usd
CY2023	us-gaap	Noncash Contribution Expense NoncashContributionExpense	92787	usd
CY2022	us-gaap	Noncash Contribution Expense NoncashContributionExpense	15192	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-49867	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15915	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-56497	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-56205	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-42071	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	104317	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	413513	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-228551	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	64876	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1213157	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2070030	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	40000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	308200	usd
CY2023	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	229729	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1805800	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	984808	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	276066	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	16000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1375128	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	976467	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1309008	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-236690	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-761022	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280877	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1041899	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44187	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280877	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	39452	usd
CY2023	ngtf	Debt And Warrants Discount Accounted On Convertible Notes DebtAndWarrantsDiscountAccountedOnConvertibleNotes	864713	usd
CY2022	ngtf	Debt And Warrants Discount Accounted On Convertible Notes DebtAndWarrantsDiscountAccountedOnConvertibleNotes	931272	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	6550	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	7950	usd
CY2023	ngtf	Deemed Dividend Associated With Warrants Dilutive Adjustment DeemedDividendAssociatedWithWarrantsDilutiveAdjustment	1136946	usd
CY2022	ngtf	Deemed Dividend Associated With Warrants Dilutive Adjustment DeemedDividendAssociatedWithWarrantsDilutiveAdjustment	381310	usd
CY2023	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	16088	usd
CY2023	ngtf	Stock Issued For Interest Payable StockIssuedForInterestPayable	33907	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. Description of Business</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nightfood Holdings, Inc. (“we”, “us”, “the Company” or “Nightfood”) is a Nevada corporation organized on October 16, 2013 to acquire all of the issued and outstanding shares of Nightfood, Inc., a New York corporation from its sole shareholder, Sean Folkson. All of our operations are conducted through its subsidiary Nightfood, Inc. We are also the sole shareholder of MJ Munchies, Inc., which owns certain intellectual property but does not have any operations as of the period covered by these financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our corporate address is 520 White Plains Road – Suite 500, Tarrytown, New York 10591 and our telephone number is 888-888-6444. We maintain a web site at www.nightfood.com, along with many additional web properties. Any information that may appear on our web site should not be deemed to be a part of this report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s fiscal year end is June 30.</p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates are used in the determination of depreciation and amortization, the valuation for non-cash issuances of common stock, and the website, income taxes and contingencies, valuing convertible preferred stock for a “beneficial conversion feature” (“BCF”) and warrants among others.</span></td> </tr></table>
CY2023Q2	ngtf	Federal Depository Insurance Coverage FederalDepositoryInsuranceCoverage	250000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	166656	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	596331	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits at financial institutions. At various times during the year, the Company may exceed the federally insured limits. To mitigate this risk, the Company places its cash deposits only with high credit quality institutions. Management believes the risk of loss is minimal. At June 30, 2023 and June 30, 2022, the Company did not have any uninsured cash deposits.</span></td> </tr></table>
CY2023	us-gaap	Profit Loss ProfitLoss	5749722	usd
CY2023	ngtf	Description Of Beneficial Conversion Feature DescriptionOfBeneficialConversionFeature	Each share of B Preferred is convertible at the option of the holder thereof into (i) 5,000 shares of the Registrant’s common stock (one share for each $0.20 of liquidation preference) (the “Conversion Shares”) and (ii) 5,000 common stock purchase warrants, expiring April 16, 2026 (the “Warrants”). The Warrants carried an initial exercise price of $0.30 per share. Subsequent financing events and debt extinguishment resulted in adjustments to the exercise price of all warrants created from conversion of B Preferred from $0.30 per share to approximately $0.1389 per share through June 30, 2023.
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	4400000
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1100000	usd
CY2023	ngtf	Cash Flow Used In Operations CashFlowUsedInOperations	1173157	usd
CY2023	ngtf	Gross Sales Rate GrossSalesRate	0.42	pure
CY2022	ngtf	Gross Sales Rate GrossSalesRate	0.20	pure
CY2023	ngtf	Percentage Of Costs Of Goods Sold PercentageOfCostsOfGoodsSold	0.48	pure
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Reclassification</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may make certain reclassifications to prior period amounts to conform with the current year’s presentation. Such reclassifications would not have a material effect on its consolidated statement of financial position, results of operations or cash flows.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q2	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	34988126	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	163644	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	165470	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63734	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	82625	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	48824	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	83436	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	276202	usd
CY2022Q2	us-gaap	Inventory Gross InventoryGross	331531	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	92726	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	137797	usd
CY2023Q2	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	92726	usd
CY2022Q2	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	137797	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	40779	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	4831	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	563737	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	229321	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	604516	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	234152	usd
CY2022Q2	ngtf	Convertible Price Per Share ConvertiblePricePerShare	0.2
CY2023Q2	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	1000000	usd
CY2023	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	100000	usd
CY2023	us-gaap	Legal Fees LegalFees	15192	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	5434783	shares
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1086957	usd
CY2023	ngtf	Forbearance Agreement Description ForbearanceAgreementDescription	The Company shall pay to each Purchaser in cash the sum of $482,250.00 for the full and complete satisfaction of the Notes, which includes all due and owing principal, interest and penalties notwithstanding anything to the contrary in the Notes, as follows: (i) $250,000.00 on or before February 7, 2023; (ii) $50,000.00 on or before February 28, 2023; (iii) $50,000.00 on or before March 31, 2023; (iv) $50,000.00 on or before April 30, 2023; and (v) $82,250.00 on or before May 31, 2023.
CY2023	ngtf	Schedule Of Exchange Of Returnable Warrants For Shares Of Common Stock ScheduleOfExchangeOfReturnableWarrantsForSharesOfCommonStock	Below is a reconciliation of the extinguishment of debt relative to the exchange of Returnable Warrants for shares of common stock by the holders:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">3,800,000 shares of common stock issued and exchanged for 10,869,566 returnable warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">342,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loss on conversion price change in December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,051,801</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock settled debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,988,402</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Financing charges due to returnable warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">987,060</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Principal increased due to penalty</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,703</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loss on extinguishment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">392,459</td><td style="text-align: left"> </td></tr> </table>
CY2023Q2	ngtf	Shares Of Common Stock Issued Returnable Warrants SharesOfCommonStockIssuedReturnableWarrants	3800000	shares
CY2023	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	10869566	shares
CY2023Q2	ngtf	Common Stock Returnable Warrants CommonStockReturnableWarrants	342000	usd
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1051801	shares
CY2023	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	1988402	usd
CY2023Q2	ngtf	Financing Charges Due To Returnable Warrants Issued FinancingChargesDueToReturnableWarrantsIssued	987060	usd
CY2023	ngtf	Under Forbearance Agreement UnderForbearanceAgreement	58703	usd
CY2023	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	392459	usd
CY2023	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	604800	usd
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	49995	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	16088	usd
CY2023Q2	ngtf	Stock Issued For Interest Payable StockIssuedForInterestPayable	33907	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1500000	shares
CY2023Q1	ngtf	Exercise Price Per Share ExercisePricePerShare	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	7000000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.3
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q1	ngtf	Purchase Issue Amount PurchaseIssueAmount	24141	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023Q1	ngtf	Warrants To Purchase Shares WarrantsToPurchaseShares	57000	shares
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.1
CY2023Q2	ngtf	Principal Amount PrincipalAmount	169941	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	24141	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023	us-gaap	Payments For Fees PaymentsForFees	6840	usd
CY2023Q2	ngtf	Principal Amount PrincipalAmount	200000	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	170000	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	30000	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.05688
CY2023Q2	ngtf	Warrants Exercise WarrantsExercise	0.033
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	55250	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	9750	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	600000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q2	ngtf	Common Stock As Commitment Shares CommonStockAsCommitmentShares	1477272	shares
CY2023Q2	ngtf	Warrants To Purchase Shares WarrantsToPurchaseShares	23021	shares
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.10
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	305696	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	0	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	74686	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	40779	usd
CY2022Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	0	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0.03333	usd
CY2023	ngtf	Outstanding Share In Percentage OutstandingShareInPercentage	0.50	pure
CY2023	ngtf	Offering Description OfferingDescription	the Company launched a Tier 2 offering pursuant to Regulation A (also known as “Regulation A+”) with the intent to raise capital through an equity crowdfunding campaign. The Company is offering (this “Offering”) up to 5,000,000 units, each unit consisting of 4 shares of common stock and 4 common stock purchase warrants (“Unit”), being offered at a price range to be determined after qualification pursuant to Rule 253(b).
CY2023Q2	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	123587968	shares
CY2022Q2	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	91814484	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023	ngtf	Cash Proceed CashProceed	532859	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	77110	usd
CY2023	ngtf	Common Stock Issued As Financing Costin Shares CommonStockIssuedAsFinancingCostinShares	2469697	shares
CY2023	ngtf	Common Stock Issued As Financing Cost CommonStockIssuedAsFinancingCost	104515	usd
CY2023	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	467950	shares
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.5
CY2023	ngtf	Common Stock Offering CommonStockOffering	1871800	shares
CY2023	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	229729	usd
CY2023	ngtf	Returnable Warrants ReturnableWarrants	10869566	shares
CY2023	ngtf	Purchase Of Warrant Shares PurchaseOfWarrantShares	2750000	shares
CY2023	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	6550000	shares
CY2023	ngtf	Aggregate Common Stock Shares AggregateCommonStockShares	5750000	shares
CY2023	ngtf	Stock Issued During Period Value Warrants Exercise In Cash StockIssuedDuringPeriodValueWarrantsExerciseInCash	276066	usd
CY2023	ngtf	Common Stock Issued Under Notice Of Conversionin Shares CommonStockIssuedUnderNoticeOfConversioninShares	1500000	shares
CY2023	us-gaap	Stock Issued1 StockIssued1	16088	usd
CY2023	ngtf	Stock Issued For Interest Payable StockIssuedForInterestPayable	33907	usd
CY2023	ngtf	Common Stock Issued Under Notice Of Conversion CommonStockIssuedUnderNoticeOfConversion	91500	usd
CY2022	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	848325	shares
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	214125	usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1600000	shares
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16000	usd
CY2022	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	8700000	shares
CY2023Q2	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	0	shares
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.264	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q2	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	335	shares
CY2023	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	0	usd
CY2022	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	335000	usd
CY2023	ngtf	Preferred Stock Issued And Outstanding Description PreferredStockIssuedAndOutstandingDescription	The Company had 1,950 and 3,260 shares of its B Preferred Stock issued and outstanding as of June 30, 2023, and June 30, 2022, respectively.
CY2023Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	5000	shares
CY2023Q2	ngtf	Warrants warrants	5000	shares
CY2023	ngtf	Transaction Amount TransactionAmount	4431387	usd
CY2023	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	1136946	usd
CY2023	ngtf	Warrants Issued WarrantsIssued	4000000	shares
CY2022	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.25
CY2022Q2	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate	1.4339	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0125	pure
CY2023	us-gaap	Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions	12870000	shares
CY2023	ngtf	Aggregate Of Shares AggregateOfShares	6549128	shares
CY2023	ngtf	Stock Purchase Warrants StockPurchaseWarrants	4928260	shares
CY2023Q2	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate	1.2175	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0406	pure
CY2023	ngtf	Purchase Warrants Description PurchaseWarrantsDescription	During the fiscal year ended June 30, 2023 the Company issued 1,871,800 warrants to various subscribers under its Tier 2 offering pursuant to Regulation A (also known as “Regulation A+”) pursuant to which the Company is offering up to 5,000,000 units at a price of $0.50 per unit, each unit consisting of 4 shares of common stock and 4 common stock purchase warrants (“Unit”) for exercise at at a strike price per Share equal to 125% of the price per share of common stock, or $0.15625 per share with a term of 2 years.
CY2023	ngtf	Aggregate Common Stock Shares AggregateCommonStockShares	5750000	shares
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	276066	usd
CY2023	ngtf	Stock Issued During Period Value Warrants Exercises In Cash StockIssuedDuringPeriodValueWarrantsExercisesInCash	6900000	shares
CY2023	ngtf	Exercise Price ExercisePrice	0.05
CY2023	ngtf	Gross Proceeds From Issuance Of Warrants GrossProceedsFromIssuanceOfWarrants	345000	usd
CY2023	ngtf	Warrant Description WarrantDescription	Certain warrants in the below table include dilution protection for the warrant holders, which could cause the exercise price to be adjusted either higher or lower as a result of various financing events and stock transactions. The result of the warrant exercise price downward adjustment on modification date is treated as a deemed dividend and fully amortized on the transaction date. In addition to the reduction in exercise price, with certain wararnts there is a corresponding increase to the number of warrants to the holder on a prorated basis. Under certain conditions, such as the successful retirement of a convertible note through repayment, it is possible for the exercise price of these warrants to increase and for the number of warrants outstanding to decrease.
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	4215000	usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	11650	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	500000	shares
CY2023	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.15
CY2022Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	1000000	usd
CY2022Q1	ngtf	Warrant Strike Price WarrantStrikePrice	0.5
CY2022Q1	us-gaap	Revenues Revenues	1000000	usd
CY2023	ngtf	Warrants Description WarrantsDescription	an additional 3,000,000 warrants with a $0.50 strike price when the Company records its first quarter with revenues over $3,000,000, and an additional 3,000,000 warrants with a $1 strike price when the Company records its first quarter with revenues over $5,000,000. Mr. Folkson will also be awarded warrants with a strike price of $0.50 should the Company exceed $500,000 in non-traditional retail channel revenue during the term of the agreement, and should the Company enter into a product development or distribution partnership with a multi-national food & beverage conglomerate during the term of the Agreement.
CY2023Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.12	pure
CY2023Q2	ngtf	Consulting Fees ConsultingFees	27000	usd
CY2022Q2	ngtf	Consulting Fees ConsultingFees	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.065	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.065	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.206	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.119	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.351	pure
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4591840	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2573365	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4591840	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2573365	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	21533500	usd
CY2023Q2	ngtf	Net Operating Loss Carry Forwards NetOperatingLossCarryForwards	2614000	usd
CY2023	ngtf	Operating Loss Carry Forwards Expiration Period Description OperatingLossCarryForwardsExpirationPeriodDescription	expire between 2031 and 2037
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.80	pure
CY2023Q2	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	2018500	usd
CY2023Q3	ngtf	Securities Purchase Amount SecuritiesPurchaseAmount	60000	usd
CY2023Q3	us-gaap	Common Stock Discount On Shares CommonStockDiscountOnShares	9000	usd
CY2023	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.1
CY2023Q4	ngtf	Principal Amount PrincipalAmount	62000	usd
CY2023	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.033
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103889833	shares
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022	ngtf	Unissued Shares Previously Allocated For Services UnissuedSharesPreviouslyAllocatedForServices		usd
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash		usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2023	ngtf	Warrants Exchange To Common Stock WarrantsExchangeToCommonStock		usd
CY2023	ngtf	Deemed Dividends Associated With Warrants Related Dilutive Adjustments DeemedDividendsAssociatedWithWarrantsRelatedDilutiveAdjustments		usd
CY2022	ngtf	Stock Issued For Financing Cost StockIssuedForFinancingCost		usd
CY2022	ngtf	Financing Cost Due To Conversion Price Changes FinancingCostDueToConversionPriceChanges		usd
CY2022	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001593001
CY2023	dei	Entity File Number EntityFileNumber	000-55406

Files In Submission

Name	View Source	Status
0001013762-23-003824-index-headers.html	Edgar Link	pending
0001013762-23-003824-index.html	Edgar Link	pending
0001013762-23-003824.txt	Edgar Link	pending
0001013762-23-003824-xbrl.zip	Edgar Link	pending
f10k2023ex10-36_nightfood.htm	Edgar Link	pending
f10k2023ex10-37_nightfood.htm	Edgar Link	pending
f10k2023ex10-38_nightfood.htm	Edgar Link	pending
f10k2023ex10-39_nightfood.htm	Edgar Link	pending
f10k2023ex10-40_nightfood.htm	Edgar Link	pending
f10k2023ex10-41_nightfood.htm	Edgar Link	pending
f10k2023ex10-42_nightfood.htm	Edgar Link	pending
f10k2023ex10-43_nightfood.htm	Edgar Link	pending
f10k2023ex10-44_nightfood.htm	Edgar Link	pending
f10k2023ex10-45_nightfood.htm	Edgar Link	pending
f10k2023ex10-46_nightfood.htm	Edgar Link	pending
f10k2023ex10-47_nightfood.htm	Edgar Link	pending
f10k2023ex10-48_nightfood.htm	Edgar Link	pending
f10k2023ex10-49_nightfood.htm	Edgar Link	pending
f10k2023ex10-50_nightfood.htm	Edgar Link	pending
f10k2023ex10-51_nightfood.htm	Edgar Link	pending
f10k2023ex10-52_nightfood.htm	Edgar Link	pending
f10k2023ex10-53_nightfood.htm	Edgar Link	pending
f10k2023ex10-54_nightfood.htm	Edgar Link	pending
f10k2023ex31-1_nightfood.htm	Edgar Link	pending
f10k2023ex32-1_nightfood.htm	Edgar Link	pending
f10k2023_nightfood.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ngtf-20230630.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ngtf-20230630_cal.xml	Edgar Link	unprocessable
ngtf-20230630_def.xml	Edgar Link	unprocessable
ngtf-20230630_lab.xml	Edgar Link	unprocessable
ngtf-20230630_pre.xml	Edgar Link	unprocessable
f10k2023_nightfood_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NGTF
NightFood Holdings, Inc. Stock $ngtf

2023 Q4 Form 10-K Financial Statement

#000101376223003824 Filed on October 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NGTF NightFood Holdings, Inc. Stock $ngtf

2023 Q4 Form 10-K Financial Statement

#000101376223003824 Filed on October 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NGTF
NightFood Holdings, Inc. Stock $ngtf